Droplet-engineered organoids recapitulate parental tissue transcriptome with inter-organoid homogeneity and inter-tumor cell heterogeneity
Organoids are expected to function as effective human organ models for precision cancer studies and drug development. Currently, primary tissue-derived organoids, termed non-engineered organoids (NEOs), are produced by manual pipetting or liquid handling that compromises organoid-organoid homogeneit...
Saved in:
| Main Authors: | Haoran Zhao, Yifan Cheng, Jiawei Li, Jiaqi Zhou, Haowei Yang, Feng Yu, Feihong Yu, Davit Khutsishvili, Zitian Wang, Shengwei Jiang, Kaixin Tan, Yi Kuang, Xinhui Xing, Shaohua Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co. Ltd.
2024-11-01
|
| Series: | Fundamental Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667325822002254 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging biotechnologies for engineering liver organoids
by: Junqi Zhao, et al.
Published: (2025-03-01) -
Progress in the Application of Organoids-On-A-Chip in Diseases
by: Qiao Geng, et al.
Published: (2024-12-01) -
Cholangiocyte organoids for disease, cancer, and regenerative medicine
by: Munemasa Nagao, et al.
Published: (2025-03-01) -
Advances, challenges and future applications of liver organoids in experimental regenerative medicine
by: Da Gong, et al.
Published: (2025-01-01) -
Organoids and organoid extracellular vesicles-based disease treatment strategies
by: Guangyin Zhou, et al.
Published: (2024-11-01)